Illumina, Inc. (ILMN)

220,00 +3,05 (+1,41%) Al cierre: 04:00PM EDT

Illumina, Inc.

5200 Illumina Way
San Diego, CA 92122
United States
858 202 4500
https://www.illumina.com

Sector(es): Healthcare
Sector: Diagnostics & Research
Empleados a tiempo completo: 11.500

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Francis A. deSouza	CEO & Director	N/A	N/A	1971
Dr. Alexander Aravanis M.D., Ph.D.	CTO & Head of Research and Product Devel.	1,05M	N/A	1977
Mr. Charles E. Dadswell	Sr. VP, Gen. Counsel & Sec.	N/A	N/A	1959
Ms. Susan H. Tousi	Chief Commercial Officer	1,04M	N/A	1969
Stephanie Campos	Pres	N/A	N/A	N/A
Dr. Joydeep Goswami M.B.A., Ph.D.	CFO, Chief Strategy & Corp. Devel. Officer	N/A	N/A	1971
Mr. Kevin Carl Pegels	Chief of Global Operations	N/A	N/A	N/A
Mr. Scott Ericksen	VP & Chief Accounting Officer	N/A	N/A	1972
Ms. Carissa Rollins	Chief Information Officer	N/A	N/A	N/A
Ms. Sallilyn Schwartz	VP of Investor Relations	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2021 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Gobierno corporativo

El ISS Governance QualityScore de Illumina, Inc., a día 1 de marzo de 2023, es 3. Las puntuaciones base son Auditoría: 1; Tablero: 3; Derechos de los accionistas: 7; Compensación: 8.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.